Ischyros New York

Overview

Ischyros New York is a multi-strategy hedge fund investing across asset classes including equity markets, commodities, and alternatives. Its strategies trade a broad range of markets spanning global interest rates, currencies, commodities, and equities, aiming to produce attractive, absolute, and risk-adjusted returns with low correlation to traditional assets and other alternative strategies. The firm has made investments in various sectors, including technology, healthcare, and financial services. Notably, it participated in the Series C funding round for Bayzat, a technology company providing insurance, payroll, and human resources software solutions, in December 2022. Additionally, Ischyros New York invested in Afresh Technologies, a company specializing in AI-powered supply chain software for fresh groceries, during its Series B funding round in 2022. Ischyros New York maintains proprietary relationships with marquee institutions and has a global investment approach, with a presence in multiple countries, including the United States, United Kingdom, United Arab Emirates, Saudi Arabia, India, Japan, China, and Israel. The firm's investment focus spans various industries, such as technology, healthcare, financial services, consumer internet, biotech, cybersecurity, deep tech, enterprise applications, enterprise infrastructure, fintech, drug delivery, energy, semiconductors, home living, transportation, gaming, jobs recruitment, and chemicals.